Loss of CMTM4 in lung cancer (LLC), melanoma (B16) or 4T1 was associated with significantly reduced subcutaneous tumor growth in vivo (Fig. 2B,C) despite a similar growth rate in vitro (Appendix Fig. S4C). Here, CMTM4 is linked to neoplasm.